STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM.
Subbiah V, et al. Among authors: ganeshan dm.
J Hematol Oncol. 2015 Jun 11;8:66. doi: 10.1186/s13045-015-0160-2.
J Hematol Oncol. 2015.
PMID: 26062823
Free PMC article.